Cello Health PLC (LON:CLL)

Cello Health PLC (LON:CLL)

Share Price
125.50 p
-0.5 (-0.40 %)
Market Cap
£131.92 m
Proactive Investors - Run By Investors For Investors

Cello Health PLC RNS Release

Block listing Interim Review

RNS Number : 1647A
Cello Health PLC
24 May 2019

24 May 2019

Cello Health plc

("Cello" or the "Company")

Additional Block Listing of Ordinary Shares

Block Listing Update


The Company announces that an application has been made to the London Stock Exchange for a block admission for 2,368,200 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.


These new Ordinary Shares will be issued and allotted from time to time pursuant to the exercise of existing options under the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010. The new Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company. Admission of the new Ordinary Shares is expected to occur on 31 May 2019.


Further to the announcement by the Company on 14 December 2018, the Company also announces that a total of 61,061 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted since that date (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing applied for at that time (the "Block Listing"). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.




Cello Health

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Group Finance Director

Cenkos Securities

  020 7397 8900

Mark Connelly

Harry Hargreaves


  020 7466 5000

Mark Court

Jamie Hooper

Sophie Wills




Name of applicant:

Cello Health plc

Name of scheme:

PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010

Period of return:


31 November 2018


23 May 2019

Balance of unallotted securities under scheme(s) from previous return:


Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):


Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


Name of contact:

Mark Bentley, Group Finance Director

Telephone number of contact:

020 7812 8460



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Cello Health PLC Timeline

April 11 2019
Big Picture
March 22 2019

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use